Intellia Therapeutics (NTLA) Shares Issued (2015 - 2026)
Intellia Therapeutics (NTLA) posted quarterly Shares Issued of $5.6 million for Q1 2026, down 4.56% year-over-year from $5.9 million in Q1 2025, and up 8.89% quarter-over-quarter from $5.2 million in Q4 2025.
Intellia Therapeutics (NTLA) Shares Issued (2015 - 2026) Analysis & Trends
Intellia Therapeutics (NTLA) has reported Shares Issued for 12 consecutive years, with $5.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Issued fell 4.56% year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $5.6 million (down 4.56% YoY), while the FY2025 annual figure was $5.2 million, down 4.42% from the prior year.
- Shares Issued grew to $5.6 million in Q1 2026 per NTLA's latest filing, from $5.2 million in the prior quarter.
- Across five years, Shares Issued topped out at $5.9 million in Q1 2023 and bottomed at $2.4 million in Q1 2022.
- Historically, Shares Issued has averaged $4.6 million across 5 years, with a median of $5.2 million in 2025.
- Annual changes were most pronounced in 2022 — Shares Issued plunged 67.49% — and 2023, when it soared 142.83%.
- Intellia Therapeutics' Shares Issued stood at $5.5 million in 2022, then decreased by 0.23% to $5.5 million in 2023, then fell by 0.85% to $5.4 million in 2024, then declined by 4.42% to $5.2 million in 2025, then gained by 8.89% to $5.6 million in 2026.
- Business Quant data shows NTLA's Shares Issued at $5.6 million in Q1 2026, $5.2 million in Q4 2025, and $4.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Intellia Therapeutics | 1.67 Bn | 1.67 Bn | - | 5.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.72 Mn |
| Jun 30, 2026 | 5.72 Mn |
| Mar 31, 2026 | 5.63 Mn |
| Mar 31, 2026 | 5.63 Mn |
| Dec 31, 2025 | 5.17 Mn |
| Dec 31, 2025 | 5.17 Mn |
| Sep 30, 2025 | 4.09 Mn |
| Sep 30, 2025 | 4.09 Mn |
| Jun 30, 2025 | 4.18 Mn |
| Jun 30, 2025 | 4.18 Mn |
| Mar 31, 2025 | 5.90 Mn |
| Mar 31, 2025 | 5.90 Mn |
| Dec 31, 2024 | 5.41 Mn |
| Dec 31, 2024 | 5.41 Mn |
| Sep 30, 2024 | 5.48 Mn |
| Sep 30, 2024 | 5.48 Mn |
| Jun 30, 2024 | 4.29 Mn |
| Jun 30, 2024 | 4.29 Mn |
| Mar 31, 2024 | 4.26 Mn |
| Mar 31, 2024 | 4.26 Mn |